To reduce late presentation of alcohol-related cirrhosis, do you recommend different primary-care triggers for advanced fibrosis evaluation in suspected MetALD/ALD (e.g., thrombocytopenia, AST>ALT, AUDIT-C patterns) than the triggers commonly used for MASLD?